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INTRODUCTION
Acetaminophen (APAP) or N-(4-hydroxyphenyl acetamide), is a commonly used over the counter medication contained in more than 125 products within the United States. APAP is widely used as an antipyretic and analgesic agent. Acetaminophen (APAP) in excessive doses can induce hepatic centrilobular necrosis (Davidson and Eastham, 1966; McJunkin et al., 1976) .
Acute administration in animals can induce similar damage to the liver within the centrilobular region (Mitchell et al., 1973 a,b; Jollow et al., 1973) .
APAP hepatotoxicity requires cytochrome P450 mediated formation of the toxic metabolite, Nacetyl-p-benzoquinoneimine (NAPQI) (Mitchell et al., 1973 b) . Glutathione (GSH) is crucial in detoxification of NAPQI. However, when excessive amounts of APAP are ingested, the formation of NAPQI is greater than the supply of GSH resulting in depletion of intracellular stores of GSH and hepatic damage.
S-adenosyl-L-methionine (SAMe) has been shown to reduce APAP hepatotoxicity by our laboratory (Valentovic et al., 2004) as well as others (Stramentinoli et al., 1979; Bray et al., 1992; Carrasco et al., 2000; Song et al., 2004) . SAMe administration just prior to APAP treatment greatly diminished the extent of centrilobular necrosis in C57BL/6 male mice when compared to animals given APAP (Valentovic et al., 2004) . SAMe has also shown beneficial effects in reducing and reversing hepatic damage induced by alcohol in humans (Lieber, 2002) and in intrahepatic cholestasis (Frezza et al., 1990 ).
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JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on jpet.aspetjournals.org Downloaded from JPET #111872 5 (SAMe) is a naturally occurring substance present in plasma and most tissues. SAMe is commercially available and marketed worldwide as a nutritional supplement that is readily available in vitamin and health food stores. SAMe is the principal methyl donor within the body, for transmethylation reactions. The major site of transmethylation reactions is the liver. SAMe is also a vital precursor for the transsulfuration pathway. The final product of the transsulfuration pathway is glutathione. SAMe is metabolized to S-adenosylhomocysteine (SAH) and then to homocysteine by a hydrolase enzyme. Homocysteine is converted to cystathionine by cystathione β-synthase and cystathionine is subsequently converted to cysteine, a precursor for GSH, by γ-cystathionase (Lu, 1998) . Cysteine is subsequently converted by glutamate-cysteine ligase (EC 6.3.2.2), the rate limiting enzyme in GSH synthesis, to γ -glutamylcysteine which is finally converted by GSH synthetase to GSH. N-acetylcysteine (NAC) is the current clinical treatment for APAP overdose. Hepatic GSH depletion is a critical component in the development of hepatic necrosis resulting in an increase in NAPQI (Nelson and Bruschi, 2003) which reacts with protein macromolecules and causes cell damage. NAC reduces APAP hepatic toxicity by increasing GSH levels and maintaining thiol status (Corcoran and Wong, 1986) . NAC reduces APAP hepatic damage by providing cysteine as a precursor for GSH (Lauterburg et al., 1983; Corcoran et al., 1985a, b) .
As mentioned above, NAC is the standard clinical antidote for APAP hepatic overdose.
Evaluation of a potential antidote, such as SAMe, would necessitate a comparison to NAC. The current study was designed to evaluate the protective effect of SAMe on APAP hepatic toxicity in comparison to the current antidote, NAC. The potential beneficial effect of SAMe to reduce This article has not been copyedited and formatted. The final version may differ from this version. Each group contained 5-10 different mice/group. Mice were fasted for 16 h prior to injection of APAP beginning with removal of food at 1700 h the previous day. Mice in the SAMe and SAMe+APAP groups were injected intraperitoneal (ip) with 1.25 mmol/kg (5 ml/kg) SAMe at 0900 h. Mice in the NAC and NAC+APAP groups were injected (ip) with 1.25 mmol/kg (5 This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on August 30, 2017 jpet.aspetjournals.org Downloaded from JPET #111872 8 ml/kg adjusted to pH 7) NAC. Immediately following treatment with SAMe or NAC, mice in the APAP, SAMe+APAP and NAC+APAP groups were injected, ip, with 300 mg/kg APAP (15 ml/kg in warm water). The VEH group was injected, ip, with water at an equivalent volume (15 ml/kg). Mice were anesthetized with carbon dioxide 4 h after APAP administration. Blood was collected by cardiac puncture using heparin rinsed 1 ml syringes (20 gauge needles) for determination of alanine aminotransferase (ALT) activity, a biomarker of liver injury. The livers were isolated, collected on ice, rinsed in ice cold Krebs buffer, blotted and weighed.
NAC high dose treatment given just prior to APAP Studies were done with a higher dose of NAC reported by other investigators to provide complete protection (Corcoran et al., 1985a, b; James et al., 2003) in order to validate our model. Mice were divided into the following groups:
vehicle treated (VEH); APAP treated (APAP), NAC (NAC-H) and NAC pretreated plus APAP (NAC-H+APAP). Each group contained 5-10 different mice/group. Animals were fasted overnight for 16 h. Mice were injected with 7.35 mmol/kg NAC (5 ml/kg in water adjusted to pH 7). Immediately after injection of NAC-H, mice were injected, ip, with 300 mg/kg APAP. Mice were anesthetized with carbon dioxide 4 h after APAP. Blood was collected via cardiac puncture.
The liver was quickly excised and rinsed in ice cold buffer. Glutathione determination Tissues (200 mg) were homogenized in 500 µl 0.5% sulfosalicylic acid and adjusted to a 1 ml volume. Total glutathione was determined using a glutathione reductase and NADPH coupled reaction with 5,5'-dithiobis(2-nitrobenzoic acid) (Griffith, 1980; Andersen, 1985) and expressed as nmol/g tissue. Glutathione disulfide (GSSG) was measured following 2-vinylpyridine derivatization (Griffith, 1980) and expressed as nmol/g tissue.
Serum enzyme assay
Lipid peroxidation Liver (200 mg) was homogenized in 1 ml Krebs buffer and the homogenizer probe was rinsed with an additional 1 ml of Krebs buffer. Lipid peroxidation was measured as described previously (Valentovic et al., 2002) . The amount of malondialdehyde (MDA) was calculated based on a standard curve (range 1-40 nmol) using MDA (Aldrich, St. Louis, Mo) and expressed as umol MDA/mg protein. Protein carbonyl (OxyBlot) Protein carbonyls were evaluated to assess whether SAMe reduced APAP mediated oxidative stress relative to NAC. Hepatic tissue was weighed, homogenized in 1 ml Krebs buffer pH 7.4 and the homogenizer probe was rinsed with 1 ml Krebs buffer. The homogenate was adjusted to 2 ml. An aliquot (200 µl) was used for protein determination using a Coomasie Blue spectrophotometric method (Valentovic et al., 1999) . The appearance of protein carbonyls was measured using an Protein Oxidation OxyBlot kit (Chemicon). The principle of the method is that modification of proteins by addition of carbonyl side chains due to oxidative stress are derivatized to 2,4-dinitirophenylhydrazone (DNP) following addition of 2,4-dinitrophenylhydrazine (DNPH). The antibody is specific for the DNP moiety on a protein.
4-Hydroxynonenal (4-HNE) Adducts
Tissue samples were adjusted to ensure equivalent protein and volumes were added to gels.
Samples and standards were run on polyacrylamide gel (12.5 % acrylamide). The gel was then transferred to a nitrocellulose membrane. To verify efficiency of transfer, the membrane was placed in Ponceau S stain for visualization. Ponceau S staining was used on all gels to ensure protein additions were comparable between all samples. The protein carbonyls were run with DNP-derivatized molecular weight standards. 
Histological preparation
RESULTS
Liver Weight, Plasma ALT and liver histological evaluation. Body weights were comparable between all treatment groups (Table 1) . APAP increased liver weight within 4 h when compared to the VEH group (Table 1) . Treatment with NAC or SAMe had no impact on liver weight as values were comparable to the VEH group. Liver weight was not elevated in the SAMe+APAP group following APAP injection (Table 1) ALT levels were evaluated in plasma collected 4 h after vehicle or APAP injection. ALT values were similar in the VEH, SAMe and NAC groups (Table 2) suggesting normal hepatic function.
APAP administration resulted in the highest increase in ALT levels which were approximately 100 fold higher than VEH values. The 1.25 mmol/kg NAC dose given just prior to APAP did not reduce ALT levels in the NAC+APAP group when compared to the APAP group. Treatment with 1.25 mmol/kg SAMe did provide partial protection from APAP toxicity as ALT levels were reduced in the SAMe+APAP group treatment relative to the APAP and NAC+APAP group providing support for the conclusion that SAMe does reduce APAP hepatic toxicity. (Figures 3-6 ) as GSH levels were decreased over 90% in the APAP group when compared to VEH, SAMe or NAC values. SAMe administration just prior to APAP partially reversed the depletion of total hepatic GSH (Figure 3) . GSH levels were higher in the SAMe+APAP group than in the APAP group but were lower than the SAMe and VEH groups suggesting that the 1.25 mmol/kg dose of SAMe was able to partially maintain hepatic thiol levels in APAP treated mice.
Total hepatic GSH levels in the 1.25 mmol/kg NAC+APAP group were comparable to mice treated with APAP ( Figure 4) . A comparison of hepatic GSH values between groups showed that SAMe+APAP were higher than NAC+APAP values ( Figure 5 ) and that SAMe+APAP was able to provide a higher GSH level. These results suggest that at the 1.25 mmol/kg dose, SAMe was more potent than NAC at protecting the liver from APAP mediated GSH depletion ( Figure 5 ).
As a positive control, experiments were conducted to validate NAC attenuation of APAP toxicity. Treatment with the higher dose (7.35 mmol/kg) of NAC (NAC-H) just prior to APAP (NAC-H+APAP) maintained total hepatic GSH at a level comparable to VEH and NAC groups ( Figure 6 ) confirming that 7.35 mmol/kg NAC was the most effective dose at preventing APAP mediated hepatic toxicity. These results were also consistent with the normal morphology observed by light microscopy of hepatic tissues.
APAP mediated oxidative stress resulted in a higher percentage of hepatic GSSG (Figures 7-9) when measured 4 h after APAP injection. The percent GSSG was not affected by equimolar dose of either SAMe or NAC as the levels were similar between the VEH, SAMe and NAC groups This Although not statistically different, the NAC+APAP group had a trend of higher GSSG than the APAP group while the levels had a trend of being lower in the SAMe+APAP group. Treatment with a high dose of NAC (NAC-H) was able to reduce oxidative stress as the percent of GSSG in the NAC-H+APAP group was comparable to VEH and NAC-H values (Figure 9 ). 
Western Blot analysis of protein carbonyls and 4-HNE
Discussion
The objective of the present study was to compare the protective effects of NAC and SAMe for APAP toxicity. The present study showed that SAMe was effective at a lower dose than NAC when administering an equivalent mmole dose. These results suggest that first SAMe is effective in reducing APAP hepatotoxicity and second, that SAMe is more potent than NAC in reducing hepatic damage in the mouse model. NAC is the drug of choice for emergency room treatment of APAP overdose (Kerr et al., 2005) .
NAC diminishes hepatic APAP toxicity by increasing glutathione levels and reducing the extent of hepatic glutathione depletion (Lauterburg et al., 1983; Corcoran et al., 1985 a,b) . Glutathione is critical for conjugation with the reactive metabolite of APAP and treatment with NAC allows generation of sufficient levels of glutathione to react with the toxic intermediate, NAPQI and prevent hepatic necrosis (Mitchell et al., 1974; Lauterburg et al., 1983; Corcoran et al., 1985a, b) .
When hepatic glutathione is depleted by APAP, NAPQI induces cell damage by arylation of hepatic proteins.
Although NAC is the drug of choice for APAP overdose, it is associated with a variety of adverse effects (Kao et al., 2003) . NAC is also not entirely protective for APAP toxicity.
Therefore, other agents should be examined for their effectiveness. Beneficial protective effects for APAP hepatotoxicity have been reported for clofibrate (Chen et al., 2002) , ribose cysteine (Lucas et al., 2000; Lucas Slitt et al., 2005) , L-cysteine glutathione mixed disulfide (Berkeley et al., 2003) and 2(RS)-n-propylthiazolidine-4(R)-carboxylic acid (Srinivasan et al., 2003) . The mechanism of APAP protection may be different between these agents and remains to be SAMe has been previously reported by our laboratory (Valentovic et al., 2004) as well as others (Stramentinoli et al., 1979; Bray et al., 1992; Carrasco et al., 2000) to reduce APAP toxicity.
SAMe is a substrate for the transsulfuration pathway which converts homocysteine ultimately to glutathione (Lu, 1998) . A potential mechanism for SAMe reduction of APAP hepatotoxicity may involve maintenance of hepatic glutathione levels, which would diminish hepatic glutathione depletion and NAPQI interaction with cellular components to induce necrosis.
In our studies hepatic glutathione levels were higher in the SAMe+APAP group when compared to the APAP treated mice suggesting that SAMe was able to reduce the extent of APAP mediated glutathione depletion. The SAMe+APAP group also had higher hepatic glutathione levels than the NAC+APAP group when comparing the equimolar dose (1.25 mmol/kg SAMe and NAC) suggesting better potency for SAMe. Glutathione levels are essential in preventing APAP toxicity as the NAC-H+APAP group treated with 7.35 mmol/kg NAC maintained hepatic glutathione levels after APAP treatment at a level comparable to VEH and NAC-H levels.
Oxidative stress has been implicated to have a role in APAP toxicity. 4-HNE is an aldehyde that is generated during lipid peroxidation which can impair cellular function (Hartley et al., 1999) . SAMe is present in many tissues in the body and acts as a principal methyl donor for transmethylation reactions especially within the liver. Transmethylation reactions are essential in maintaining normal cell function as SAMe is the methyl donor for transmethylation of phospholipids, proteins, nucleic acids and ultimately DNA (Mato et al., 1997; Lieber and Packer, 2002) . Very little is known regarding the effect of exposure to toxicants and alterations in the transmethylation pathway. Imbalances in SAMe and the transmethylation byproduct, Sadenosylhomocysteine (SAH) do occur in chronic alcohol models (Lieber, 2002; Lu and Mato, 2005 ). An imbalance in the relative ratio of SAMe:SAH can lead to impaired transmethylation reactions (Lu and Mato, 2005) which would be predicted to deter tissue repair and cell function.
Further studies are needed to determine whether APAP alters the balance of SAMe:SAH and transmethylation reactions as part of its mechanism of toxicity.
In summary, our study is the first to compare SAMe with NAC on effectiveness as an antidote for APAP toxicity. Equimolar administration of 1.25 mmol/kg SAMe or NAC just prior to APAP injection showed SAMe was more effective than NAC in reducing APAP hepatic toxicity. NAC administered at a higher dose of 7.35 mmol/kg provided the best protection of APAP toxicity.
This study was also the first to provide a comparison of APAP hepatic toxicity when SAMe and This article has not been copyedited and formatted. The final version may differ from this version. 
